FDA includes stent grafts in tracking list

08/27/2008 | FDAnews

The FDA has included thoracic aortic aneurysm stent grafts in a list of medical devices that require monitoring, according to a final guidance issued last week. Class II or III devices may be subjected to the FDA's tracking requirements because of various factors, including risk of adverse health effects.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA